PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Dexamethasone - Nausea and vomiting (chemotherapy induced)
PAD Profile : Dexamethasone - Nausea and vomiting (chemotherapy induced)
Traffic Light Status
Status 1 of 2.
Status :
Blue
Important
Formulations :
- Oral solution
- Tablets
Important Information :
On request from the specialist / Cancer Centre
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Guidelines
No guidelines returned.
Other Drugs
- Palonosetron with netupitant
- Nabilone
- Cyclizine hydrochloride
- Domperidone
- Metoclopramide hydrochloride
- Ondansetron hydrochloride
- Olanzapine
- Haloperidol
- Prochlorperazine maleate
- Aprepitant
- Fosaprepitant
- Levomepromazine hydrochloride
- Granisetron
- Palonosetron hydrochloride
- Netupitant/palonosetron hydrochloride
Other Indications
- Uveitis
- Retinal Vein Occlusion
- Diabetic macular oedema
- Eye inflammation
- Eye inflammation and bacterial infection
- Eye inflammation and bacterial infection
- Ocular surgery
- Nausea and vomiting (post operative)
- Congenital adrenal hyperplasia
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
06 November 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
04. Central Nervous System
04.06.00. Drugs used in nausea and vertigo